Who We Are
We're building TargetOS, the reasoning engine for drug target discovery.
The team combines deep expertise in causal AI, scientific machine learning, and drug target biology. We've built production AI systems at companies from early-stage to public listing, and we've done target discovery and validation inside pharma.
The Leadership Team:
Sina Salek, PhD | Co-Founder
Sina leads the development of TargetOS. His background is in theoretical physics and machine learning, with research at Oxford and Hong Kong University. In industry, he led causal inference at Babylon Health and built hybrid mechanistic-neural models for cell therapy manufacturing at Ori Biotech. At Geodesic Labs, he designed the platform's causal AI foundation and the architecture that integrates statistical genetics, network biology, and frontier ML into one system.
Chris Lucas, PhD | Co-Founder
Chris is an experimental physicist with a background at CERN and the University of Bristol. Over the past decade he has built production ML systems across healthcare, insurance, and climate science, including research leadership at Babylon Health and Tractable. He currently leads the Machine Learning group at Fathom, working at the intersection of climate modelling and geospatial intelligence. At Geodesic Labs, Chris advises on technical architecture and model validation.
Our team includes domain specialists with experience in pharmaceutical R&D, target validation, and computational biology at leading biotech and pharma companies.